Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)
China · Delayed Price · Currency is CNY 6.38
-0.50 (-7.27%)
Jul 29, 2026, 3:00 PM CST
SHA:603567 Revenue
Heilongjiang ZBD Pharmaceutical had revenue of 181.56M CNY in the quarter ending March 31, 2026, a decrease of -61.28%. This brings the company's revenue in the last twelve months to 509.95M, down -75.19% year-over-year. In the year 2025, Heilongjiang ZBD Pharmaceutical had annual revenue of 797.34M, down -70.51%.
Revenue (ttm)
509.95M
Revenue Growth
-75.19%
P/S Ratio
11.75
Revenue / Employee
260.05K
Employees
1,961
Market Cap
5.99B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 797.34M | -1.91B | -70.51% |
| Dec 31, 2024 | 2.70B | -434.25M | -13.84% |
| Dec 31, 2023 | 3.14B | -1.08B | -25.53% |
| Dec 31, 2022 | 4.21B | 87.33M | 2.12% |
| Dec 31, 2021 | 4.13B | 723.07M | 21.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition